Compare FDS & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDS | WST |
|---|---|---|
| Founded | 1978 | 1923 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 20.2B |
| IPO Year | 1996 | N/A |
| Metric | FDS | WST |
|---|---|---|
| Price | $289.93 | $280.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $352.78 | $346.78 |
| AVG Volume (30 Days) | ★ 877.4K | 661.6K |
| Earning Date | 12-18-2025 | 10-23-2025 |
| Dividend Yield | ★ 1.51% | 0.31% |
| EPS Growth | ★ 11.79 | 0.17 |
| EPS | ★ 15.55 | 6.75 |
| Revenue | $2,321,748,000.00 | ★ $3,017,900,000.00 |
| Revenue This Year | $6.17 | $7.01 |
| Revenue Next Year | $5.44 | $6.20 |
| P/E Ratio | ★ $18.69 | $41.51 |
| Revenue Growth | ★ 5.39 | 4.92 |
| 52 Week Low | $250.50 | $187.43 |
| 52 Week High | $496.90 | $348.90 |
| Indicator | FDS | WST |
|---|---|---|
| Relative Strength Index (RSI) | 62.87 | 55.28 |
| Support Level | $273.00 | $269.08 |
| Resistance Level | $281.85 | $285.54 |
| Average True Range (ATR) | 6.54 | 7.15 |
| MACD | 2.34 | 1.29 |
| Stochastic Oscillator | 94.67 | 82.62 |
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for roughly 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.